Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion and Optimization of Dysport for Cervical Dystonia
NCT04270214Unknown
- Sponsor
- Western University
- Start
- Jun 2020
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Western University. Primary endpoint: waning effect at 12 weeks. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT04270214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270214.